Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Biedermann

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Endoscopy|June 4, 2025
Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitisAlain M Schoepfer, Luc Biedermann, Andrea Kreienbuehl, et al.
Inflammatory Bowel Diseases|April 19, 2018
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD CohortMatiar Madanchi, Stefania Fagagnini, Nicolas Fournier, et al.
Endoscopy|June 18, 2025
Correction: Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitisAlain M Schoepfer, Luc Biedermann, Andrea Kreienbuehl, et al.
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Inflammatory Intestinal Diseases|October 1, 2020
Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease CourseJulian Burla, Sena Bluemel, Luc Biedermann, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohortFelicitas Ditrich, Sena Blümel, Luc Biedermann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2026
Disease course of eosinophilic esophagitis under anti-inflammatory treatmentAlain Schoepfer, Sofia Asikainen, Catherine Saner, et al.
Therapeutic Advances in Gastroenterology|February 13, 2020
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort studyLorenz Grob, Sena Bluemel, Luc Biedermann, et al.
Inflammatory Bowel Diseases|July 30, 2014
Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISHLuc Biedermann, Karin Brülisauer, Jonas Zeitz, et al.
Plos One|May 24, 2016
The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel DiseaseMarius Vögelin, Luc Biedermann, Pascal Frei, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Endoscopy|June 4, 2025
Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitisAlain M Schoepfer, Luc Biedermann, Andrea Kreienbuehl, et al.
Inflammatory Bowel Diseases|April 19, 2018
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD CohortMatiar Madanchi, Stefania Fagagnini, Nicolas Fournier, et al.
Endoscopy|June 18, 2025
Correction: Clinical effectiveness of esophageal stricture dilation using an improved endoscopic attachment cap in adults with eosinophilic esophagitisAlain M Schoepfer, Luc Biedermann, Andrea Kreienbuehl, et al.
Digestion|October 12, 2012
First-line therapies in inflammatory bowel diseaseMarc Girardin, Michael Manz, Christine Manser, et al.
Inflammatory Intestinal Diseases|October 1, 2020
Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease CourseJulian Burla, Sena Bluemel, Luc Biedermann, et al.
Therapeutic Advances in Gastroenterology|December 7, 2020
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohortFelicitas Ditrich, Sena Blümel, Luc Biedermann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2026
Disease course of eosinophilic esophagitis under anti-inflammatory treatmentAlain Schoepfer, Sofia Asikainen, Catherine Saner, et al.
Therapeutic Advances in Gastroenterology|February 13, 2020
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort studyLorenz Grob, Sena Bluemel, Luc Biedermann, et al.
Inflammatory Bowel Diseases|July 30, 2014
Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISHLuc Biedermann, Karin Brülisauer, Jonas Zeitz, et al.
Plos One|May 24, 2016
The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel DiseaseMarius Vögelin, Luc Biedermann, Pascal Frei, et al.
Pageof 21